Repro Med Systems (KRMD) Tops Q4 EPS by 2c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts KRMD Hot Sheet
Join SI Premium – FREE
Repro Med Systems (NASDAQ: KRMD) reported Q4 EPS of ($0.04), $0.02 better than the analyst estimate of ($0.06). Revenue for the quarter came in at $7.34 million versus the consensus estimate of $7.38 million.
GUIDANCE:
Repro Med Systems sees FY2023 revenue of $32.5-33.5 million, versus the consensus of $30.914 million.
For earnings history and earnings-related data on Repro Med Systems (KRMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- American Superconductor (AMSC) Misses Q2 EPS by 2c ; Offers Guidance
- Klaviyo, Inc. (KVYO) Tops Q3 EPS by 26c, Beats on Revenue; Offers FY26 Revenue Guidance
- AppLovin (APP) Tops Q3 EPS by 26c, Beats on Revenue; Offers Q4 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
